Abbott

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Abbott 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABT

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. 

CEO
Robert B. Ford
CEORobert B. Ford
Employees
114,000
Employees114,000
Headquarters
Abbott Park, Illinois
HeadquartersAbbott Park, Illinois
Founded
1888
Founded1888
Employees
114,000
Employees114,000

ABT Key Statistics

Market cap
214.79B
Market cap214.79B
Price-Earnings ratio
15.59
Price-Earnings ratio15.59
Dividend yield
1.90%
Dividend yield1.90%
Average volume
5.62M
Average volume5.62M
High today
$124.52
High today$124.52
Low today
$123.02
Low today$123.02
Open price
$124.23
Open price$124.23
Volume
7.08M
Volume7.08M
52 Week high
$141.23
52 Week high$141.23
52 Week low
$110.86
52 Week low$110.86

Stock Snapshot

As of today, Abbott(ABT) shares are valued at $123.30. The company's market cap stands at 214.79B, with a P/E ratio of 15.59 and a dividend yield of 1.9%.

During the trading session on 2026-01-15, Abbott(ABT) shares reached a daily high of $124.52 and a low of $123.02. At a current price of $123.30, the stock is +0.2% higher than the low and still -1.0% under the high.

Trading volume for Abbott(ABT) stock has reached 7.08M, versus its average volume of 5.62M.

The stock's 52-week range extends from a low of $110.86 to a high of $141.23.

The stock's 52-week range extends from a low of $110.86 to a high of $141.23.

ABT News

Simply Wall St 57m
Assessing Abbott Laboratories Valuation After The CES 2026 Launch Of Libre Assist AI Tool

Abbott Laboratories (ABT) is back in focus after unveiling Libre Assist, an AI driven feature within its Libre app at CES 2026. The new tool is aimed at helping...

Assessing Abbott Laboratories Valuation After The CES 2026 Launch Of Libre Assist AI Tool
24/7 Wall St. 9h
Abbott Raises Dividend 6.8% With 60% FCF Payout Ratio And Debt Down 15%

Abbott Laboratories (ABT) raised its quarterly dividend to $0.63 for a 6.8% increase. Abbott has now increased dividends for 52 consecutive years. This post ma...

Simply Wall St 2d
The Bull Case For Abbott Laboratories Could Change Following Libre Assist AI Launch In Diabetes Care

In early January 2026, Abbott Laboratories launched Libre Assist, a new generative AI feature within its Libre app that helps people with diabetes in the U.S. p...

The Bull Case For Abbott Laboratories Could Change Following Libre Assist AI Launch In Diabetes Care

Analyst ratings

68%

of 31 ratings
Buy
67.7%
Hold
32.3%
Sell
0%

More ABT News

Nasdaq 6d
S&P 500 Analyst Moves: ABT

The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Abbott Laboratories is now the #97 an...

S&P 500 Analyst Moves: ABT

People also own

Based on the portfolios of people who own ABT. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .